Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92


Overexpression of KAI1 Protein in Diabetic Skin Tissues.

Cho MK, Kwon SB, Kim CH, Lee YJ, Nam HS, Lee SH.

Arch Plast Surg. 2014 May;41(3):248-52. doi: 10.5999/aps.2014.41.3.248. Epub 2014 May 12.


Expression of extracellular superoxide dismutase protein in diabetes.

Kim CH.

Arch Plast Surg. 2013 Sep;40(5):517-21. doi: 10.5999/aps.2013.40.5.517. Epub 2013 Sep 13.


Decreased Expression of Type 5 17β-Hydroxysteroid Dehydrogenase (AKR1C3) Protein Identified in Human Diabetic Skin Tissue.

Cho MK.

Ann Dermatol. 2013 Nov;25(4):423-7. doi: 10.5021/ad.2013.25.4.423. Epub 2013 Nov 30.


MRP-1/CD9 and KAI1/CD82 expression in normal and various cancer tissues.

Huang C, Taki T, Adachi M, Yagita M, Sawada S, Takabayashi A, Inufusa H, Yoshie O, Miyake M.

Int J Oncol. 1997 Nov;11(5):1045-51.


Expression and clinical significance of CD82/KAI1 and E-cadherin in non-small cell lung cancer.

Shiwu WU, Lan Y, Wenqing S, Lei Z, Yisheng T.

Arch Iran Med. 2012 Nov;15(11):707-12. doi: 0121511/AIM.0012.


[Expression of CD82/KAI1 and HIF-1α in non-small cell lung cancer and their relationship to vasculogenic mimicry].

Wu S, Cheng Z, Yu L, Song W, Tao Y.

Zhongguo Fei Ai Za Zhi. 2011 Dec;14(12):918-25. doi: 10.3779/j.issn.1009-3419.2011.12.04. Chinese.


Expression and clinical significance of p53, JunB and KAI1/CD82 in human hepatocellular carcinoma.

Guo C, Liu QG, Zhang L, Song T, Yang X.

Hepatobiliary Pancreat Dis Int. 2009 Aug;8(4):389-96.


KAI1/CD82 expression in nonsmall cell lung carcinoma is a novel, favorable prognostic factor: an immunohistochemical analysis.

Higashiyama M, Kodama K, Yokouchi H, Takami K, Adachi M, Taki T, Ishiguro S, Nakamori S, Yoshie O, Miyake M.

Cancer. 1998 Aug 1;83(3):466-74.


Frequent loss of KAI1 expression in squamous and lymphoid neoplasms. An immunohistochemical study of archival tissues.

Geradts J, Maynard R, Birrer MJ, Hendricks D, Abbondanzo SL, Fong KM, Barrett JC, Lombardi DP.

Am J Pathol. 1999 Jun;154(6):1665-71.


Nuclear factor-kappaB-dependent expression of metastasis suppressor KAI1/CD82 gene in lung cancer cell lines expressing mutant p53.

Shinohara T, Miki T, Nishimura N, Nokihara H, Hamada H, Mukaida N, Sone S.

Cancer Res. 2001 Jan 15;61(2):673-8.


Correlation of KAI1/CD82 gene expression with good prognosis in patients with non-small cell lung cancer.

Adachi M, Taki T, Ieki Y, Huang CL, Higashiyama M, Miyake M.

Cancer Res. 1996 Apr 15;56(8):1751-5.


Metastasis suppressor KAI1/CD82 attenuates the matrix adhesion of human prostate cancer cells by suppressing fibronectin expression and β1 integrin activation.

Lee HA, Park I, Byun HJ, Jeoung D, Kim YM, Lee H.

Cell Physiol Biochem. 2011;27(5):575-86. doi: 10.1159/000329979. Epub 2011 Jun 15.


Role of tumor metastasis suppressor gene KAI1 in digestive tract carcinomas and cancer cells.

Wu Q, Ji Y, Zhang MQ, Chen YQ, Chen F, Shi DL, Zheng ZH, Huang YJ, Su WJ.

Cell Tissue Res. 2003 Nov;314(2):237-49. Epub 2003 Sep 3.


Motility-related protein (MRP-1/CD9) and KAI1/CD82 expression inversely correlate with lymph node metastasis in oesophageal squamous cell carcinoma.

Uchida S, Shimada Y, Watanabe G, Li ZG, Hong T, Miyake M, Imamura M.

Br J Cancer. 1999 Mar;79(7-8):1168-73.


Identifying CD82 (KAI1) as a marker for human chromophobe renal cell carcinoma.

Yusenko MV, Kovacs G.

Histopathology. 2009 Dec;55(6):687-95. doi: 10.1111/j.1365-2559.2009.03449.x.


KAI1 protein is down-regulated during the progression of human breast cancer.

Yang X, Wei L, Tang C, Slack R, Montgomery E, Lippman M.

Clin Cancer Res. 2000 Sep;6(9):3424-9.


Elevated aurora kinase a protein expression in diabetic skin tissue.

Cho MK, An JM, Kim CH, Kang SG.

Arch Plast Surg. 2014 Jan;41(1):35-9. doi: 10.5999/aps.2014.41.1.35. Epub 2014 Jan 13.


Reduced expression of the metastasis suppressor gene KAI1 in advanced colon cancer and its metastases.

Maurer CA, Graber HU, Friess H, Beyermann B, Willi D, Netzer P, Zimmermann A, Büchler MW.

Surgery. 1999 Nov;126(5):869-80.


KAI1/CD82 and cyclin D1 as biomarkers of invasion, metastasis and prognosis of laryngeal squamous cell carcinoma.

Zhang B, Liu W, Li L, Lu J, Liu M, Sun Y, Jin D.

Int J Clin Exp Pathol. 2013 May 15;6(6):1060-7. Print 2013.

Items per page

Supplemental Content

Write to the Help Desk